RARE SALAMI trial revisited

Rasmussen, Helge H; Hansen, Peter S; Nelson, Gregory I C

doi:10.5694/j.1326-5377.2002.tb04900.x

Topics

To the Editor: According to the article by Kennedy in the Journal,1 we failed to address the objections to the RARE SALAMI trial (the Royal North Shore and Ambulance Regional Study of a Stenting Strategy as an Alternative to Lytic/Medical Therapy in Acute Myocardial Infarction) in our account of the fate of this trial.2

Correspondence: helger@med.usyd.edu.au

1. Kennedy MC. Clinical trials without consent: some experiments simply cannot be done. Med J Aust 2002; 177: 40-42. <MJA full text>
2. Rasmussen HH, Hansen PS, Koyama Y, et al. Trial of a trial by media. Med J Aust 2001; 175: 625-628. <MJA full text>
3. Heart Attack Every Minute Counts. Information from the Heart Foundation. Available at: http://www.heartfoundation.com.au/index.cfm?page=185 (accessed September 2002).
4. The Danish Multicenter Randomised Trial of Thrombolytic Therapy Versus Coronary Angioplasty in Acute Myocardial Infarction. Presented as Late Breaking Clinical Trial at the 51st Annual Scientific Session of the American College of Cardiology. Abstract available at: http://www.meetingcast.com/acc02wc/index.php3?l=faculty#andersen (accessed September 2002). Slides of presentations available at: http://www.danami-2.dk/newslet/apr02/apr02main_results.htm (accessed September 2002).
5. Thiemann DR. Primary angioplasty for elderly patients with myocardial infarction [editorial]. Theory, practice and possibilities. J Am Coll Cardiol 2002; 39: 1729-1732.
6. Ryle G. A trial of the heart. The Sydney Morning Herald 2001; 29 March: 11.

Online responses are no longer available. Please refer to our instructions for authors page for more information.